- 专利标题： Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
-
申请号： US17876433申请日： 2022-07-28
-
公开(公告)号： US11866442B2公开(公告)日： 2024-01-09
- 发明人: Daniel W. Robbins , Arthur T. Sands , Joel McIntosh , Jeffrey Mihalic , Jeffrey Wu , Daisuke Kato , Dahlia Weiss , Ge Peng
- 申请人： NURIX THERAPEUTICS, INC.
- 申请人地址： US CA San Francisco
- 专利权人： NURIX THERAPEUTICS, INC.
- 当前专利权人： NURIX THERAPEUTICS, INC.
- 当前专利权人地址： US CA San Francisco
- 代理机构： Squire Patton Boggs (US) LLP
- 主分类号： C07D487/10
- IPC分类号： C07D487/10 ; C07D413/14 ; C07D491/107 ; C07D498/10 ; C07D471/10 ; C07D401/14 ; C07D417/14 ; C07D487/04
摘要：
The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
公开/授权文献
信息查询
